Literature DB >> 21210830

Fixed drug eruption caused by etoricoxib--2 cases confirmed by patch testing.

Pedro Andrade1, Margarida Gonçalo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21210830     DOI： 10.1111/j.1600-0536.2010.01847.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN： 0105-1873            Impact factor:   6.600


× No keyword cloud information.
  4 in total

1.  Celecoxib-induced bullous fixed drug eruption: An unusual presentation.

Authors:  Helmi Ammar; Nadia Ben Fredj; Najeh Ben Fadhel; Zohra Chadli; Haifa Ben Romdhane; Naceur A Boughattas; Amel Chaabane; Karim Aouam
Journal:  Br J Clin Pharmacol       Date:  2019-08-02       Impact factor: 4.335

2.  Fixed drug eruption by etoricoxib confirmed by patch test.

Authors:  Aline Soares de Sousa; José Carlos Cardoso; Miguel Pinto Gouveia; Ana Rita Gameiro; Vera Barreto Teixeira; Maria Gonçalo
Journal:  An Bras Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.896

3.  Evaluation of Subjects Experiencing Allergic Reactions to Non-Steroidal Anti-Inflammatory Drugs: Clinical Characteristics and Drugs Involved.

Authors:  Natalia Pérez-Sánchez; Inmaculada Doña; Gador Bogas; María Salas; Almudena Testera; José A Cornejo-García; María J Torres
Journal:  Front Pharmacol       Date:  2020-04-21       Impact factor: 5.810

Review 4.  The Role of Patch Testing in Evaluating Delayed Hypersensitivity Reactions to Medications.

Authors:  Carina M Woodruff; Nina Botto
Journal:  Clin Rev Allergy Immunol       Date:  2022-02-03       Impact factor: 10.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.